CIK 0001517022
- Large accelerated filer
Akebia Therapeutics, Inc.
Sign in to watch- Ticker
- AKBA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 208756903
- Phone
- +1 617-871-2098
- Business address
- 180 THIRD AVENUE, FLOOR 2, WALTHAM, MA, 02451
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4/A Derivatives Options or other derivatives
- 4 Open-market sale SVP, General Counsel, Sec. sold 1,556 shares at $9.41 ($14,642)
- 4 Open-market sale SVP, Chief Business Officer sold 1,401 shares at $9.41 ($13,183)
- 3 Insider Initial Statement of Ownership
- 4 Grant or award SVP and Chief Medical Officer acquired 36,500 shares (grant or award)
- 4 Grant or award SVP, General Counsel, Sec. acquired 22,500 shares (grant or award)
- 4 Grant or award CEO and President acquired 125,500 shares (grant or award)
- 4 Grant or award SVP, CFO & Treasurer acquired 26,000 shares (grant or award)
- 4 Exercise or conversion CEO and President acquired 25,000 shares (option exercise)
- 4 Open-market sale SVP, General Counsel, Sec. sold 1,811 shares at $12.28 ($22,239)
- 4 Open-market sale Director sold 996 shares at $8.65 ($8,617)
- 4 Open-market sale SVP, General Counsel, Sec. sold 1,484 shares at $8.67 ($12,860)
- 4 Open-market sale Director sold 996 shares at $9.53 ($9,490)
Page 15 of 19 · 378 filings